API

API / product groups & items in this category
We produce and provide active pharmaceutical ingredients (APIs) of interest to the chemical and biochemical industries.

Active pharmaceutical ingredient (API) chemicals

Intermediates, including heterocyclic derivatives, are of interest due to their wide application in the synthesis of macromolecules and their role in the production of API.
    • Ataluren
      Ataluren is a low-molecular-weight synthetic compound, representing a derivative of 1,2,4-oxadiazole and benzoic acid, containing a fluorophenyl fragment in its structure.
    • Cabozantinib
      Cabozantinib is a low-molecular-weight synthetic compound derived from quinoline and cyclopropane-1,1-dicarboxamide, containing dimethoxy and fluorophenyl fragments in its structure.
    • Enzalutamide
      Enzalutamide is a low-molecular-weight synthetic compound derived from benzamide and imidazolidine-2,4-dione (hydantoin), containing fluorophenyl, cyanophenyl, and trifluoromethyl fragments in its structure.
    • Olaparib
      Olaparib is a low-molecular-weight synthetic compound belonging to the class of N-acylpiperazines, representing a derivative of phthalazine and cyclopropanecarbonylpiperazine, containing a fluorophenyl fragment in its structure.
    • Palbociclib
      Palbociclib is a low-molecular-weight synthetic compound belonging to the pyrido[2,3-d]pyrimidine class, characterized by the presence of cyclopentyl and acetyl groups within its core cyclic system and a piperazinyl-pyridine fragment as a side chain.
    • Regorafenib
      Regorafenib is a low-molecular-weight synthetic derivative of pyridinecarboxamide and diphenylurea, containing fluorophenyl, chlorophenyl, and trifluoromethyl fragments in its structure.
    • Tegoprazan
      Tegoprazan is a low-molecular-weight synthetic compound, representing a benzimidazole derivative containing difluorochromane and trimethylbenzamide fragments in its structure.
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.